Back

Optimizing the treatment of acute cardiac rejection: combination therapy of ECMO, plasmapheresis and immunoglobulin, a promising approach for humoral and cellular cardiac recovery

11 May 2024 (12:11 - 12:22)
Organised by: Logo
Congress Presentation Part of: Challenges following heart transplantation Clinical HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Juan David Rojas

Shaio Clinic Foundation, Bogota (Colombia)

3 More presentations in this session

Presentation thumbnail
A case of disseminated cryptococcosis in the early period of a heart transplant
Doctor D. Holguin Riano (Bogota, CO)
Slides Video
Presentation thumbnail
Eosinophilic endomyocarditis after COVID-19 infection in a heart transplant recipient
Doctor F. Alexandrino (Rochester, US)
Slides Video
Presentation thumbnail
Afterload-dependent severe mitral regurgitation: seek and you will find
Doctor C. Pereira Mateus (Amadora, PT)
Slides Video

Access the full session

Session thumbnail
Challenges following heart transplantation

The Event

Event poster

Heart Failure 2024

11 May 2024 12:11 CET
You may be interested in
thumbnail
Congress Presentation
Eculizumab as rescue therapy for severe antibody-mediated rejection after heart transplantation in complex congenital heart disease
thumbnail
Congress Presentation
Rescuing the failing graft: hybrid peripheral-central VA-ECMO cannulation as a bridge to recovery after heart transplantation
thumbnail
Congress Presentation
A case of cellular and humoral rejection in hyperimmunized patient post heart transplantation: management of a complex clinical scenario

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources